Cargando…
吉西他滨调整方案治疗晚期非小细胞肺癌的Ⅱ期临床试验
BACKGROUND AND OBJECTIVE: Gemcitabine-platinum-combined with chemotherapy is the most common treatment for advanced non-small cell lung cancer (NSCLC). Gemcitabine is administered once a week in a general three-week schedule. In the present study, gemcitabine is administered on d1 and d5 to improve...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999965/ https://www.ncbi.nlm.nih.gov/pubmed/22237116 http://dx.doi.org/10.3779/j.issn.1009-3419.2012.01.01 |